Task: Answer Verification
Input (English): Question: Do combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers?
Answer: Clinically defined AVPC share molecular features with SCPC and are characterized by combined alterations in RB1, Tp53, and/or PTEN.
Output (English): yes